Türkçe
Abstract Objective: This study aims to determine the coinfection rate of hospitalized COVID-19 patients, investigate the etiological agents causing coinfection, and reveal the clinical characteristics of patients with coinfection. In addition, by identifying coinfections accompanying viral infections, we aim to prevent unnecessary antibiotic use and antimicrobial resistance. Methods: This study analyzed 76 hospitalized patients with prediagnoses of COVID-19 between Sep 2021 and Feb 2022. They had a positive RT-PCR test for SARS-CoV-2, compatible thoracic Computed Tomography findings, and biochemical parameters indicating coinfection. Patients’ respiratory samples were tested for other respiratory pathogens by multiplex PCR. Results: Out of 76 patients, 54 (71.1%) were found to have one or more pathogens along with SARS-CoV-2. Among these patients, 35 had a single pathogen, while 19 had multiple pathogens. The most common pathogens were Staphylococcus aureus in 24 (31.6%) patients, influenza viruses in 18 patients (23.7%), and Streptococcus pneumoniae in 15 (17.1%) patients. There was no significant difference between mortality rates, length of hospital stay, hospitalization site, b
Okumak, EPUB indirmek veya dinlemek için ücretsiz hesabınla giriş yap.
Sabiha Salar-Gül, Nurullah Çiftçi, Hatice Türk-Dağı, Uğur Arslan · CC BY-ND 4.0
E-kitap · Investigation of Respiratory Pathogens Responsible for Coinfection in COVID-19 Patients · Sabiha Salar-Gül, Nurullah Çiftçi, Hatice Türk-Dağı, Uğur Arslan · Internet Archive
COVID-19 · coinfection · polymerase chain reaction